https://www.fiercebiotech.com/biotech/jpm24-lilly-ceo-david-ricks-biotechs-were-open-business
Lilly open for business on external innovation.
“We think about now, acquisition is not just assets, but people and methodologies and ways to make even more medicines,” Ricks said. “Surely one of the ways that Big Pharma can grow R&D productively is by having more great minds around the table and more difference in how we think about creating drugs.”
Hard to go past our managements experience and track record.
https://www.fiercebiotech.com/biotech/jpm24-lilly-ceo-david-ricks...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.060M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.5¢ | 0.4¢ | $11.72K | 2.783M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 2757364 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 15260220 | 25 |
View Market Depth
| Last trade - 16.10pm 23/06/2025 (20 minute delay) ? |
| CHM (ASX) Chart |